Novo Nordisk's pricing approaches while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of price tag gouging, mentioning the stark distinction involving U.S. costs and those in Europe and copyright.Scientific studies of Rybelsus and copyright have revealed that equally drugs are efficient